سعر Xatral SR 5 mg 28 f.c. tab 2026

معلومات الدواء

الآثار الجانبيةSide effects

Dizziness, upper respiratory tract infection, headache and fatigue (>=2% and more than placebo).نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)

Dizziness, upper respiratory tract infection, headache and fatigue (>=2% and more than placebo).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

موانع الاستعمالContraindications

Moderate or severe hepatic impairment (Child-Pugh B and C).نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)
Co-administration with potent CYP3A4 inhibitors such as ketoconazole, itraconazole or ritonavir.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)
Known hypersensitivity to alfuzosin or any component.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)

Moderate or severe hepatic impairment (Child-Pugh B and C).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
Co-administration with potent CYP3A4 inhibitors such as ketoconazole, itraconazole or ritonavir.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
Known hypersensitivity to alfuzosin or any component.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

تحذيرات واحتياطاتWarnings & precautions

Postural hypotension/syncope, especially with antihypertensives or nitrates.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)
Use with caution in severe renal impairment (CrCl <30 mL/min) and in mild hepatic impairment.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)
Do not combine with other alpha-adrenergic antagonists.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)

Postural hypotension/syncope, especially with antihypertensives or nitrates.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
Use with caution in severe renal impairment (CrCl <30 mL/min) and in mild hepatic impairment.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
Do not combine with other alpha-adrenergic antagonists.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

التداخلات الدوائيةDrug interactions

Potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir)Contraindicated; alfuzosin levels increased.DailyMed (U.S. National Library of Medicine)
PDE5 inhibitorsPossible symptomatic hypotension; use with caution.DailyMed (U.S. National Library of Medicine)

Potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir)Contraindicated; alfuzosin levels increased.DailyMed (U.S. National Library of Medicine)
PDE5 inhibitorsPossible symptomatic hypotension; use with caution.DailyMed (U.S. National Library of Medicine)

الحمل والرضاعةPregnancy & breastfeeding

Not indicated for use in women; no adequate human data; animal studies not teratogenic.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)

Not indicated for use in women; no adequate human data; animal studies not teratogenic.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.